{"id":576646,"date":"2019-03-30T00:00:00","date_gmt":"2019-03-30T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/rwbton0001-2019-biopharma-immune-checkpoint-inhibitors-real-world-brand-tracker-us-2019\/"},"modified":"2026-05-10T11:35:57","modified_gmt":"2026-05-10T11:35:57","slug":"rwbton0001-2019-biopharma-immune-checkpoint-inhibitors-real-world-brand-tracker-us-2019","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/rwbton0001-2019-biopharma-immune-checkpoint-inhibitors-real-world-brand-tracker-us-2019\/","title":{"rendered":"Immune Checkpoint Inhibitors | Real World Brand Tracker | US | 2019"},"content":{"rendered":"<p>Immune checkpoint inhibitors\u00a0continue to revolutionize current oncology treatment.\u00a0\u00a0Driven by Decision Resources Group\u2019s\u00a0in-house oncology experts\u00a0and robust real-world data\u00a0capabilities, the Real World Brand Tracker captures\u00a0U.S. claims data\u00a0to uncover shifting market dynamics and the impact of events on the immune checkpoint inhibitor space, in order to help refine your oncology brand strategies. We cover every approved immune checkpoint inhibitor for every approved oncology indication and monitor the\u00a0trends in\u00a0use and reimbursement dynamics over time.<\/p>\n<p><strong>Questions answered:<\/strong><\/p>\n<ul>\n<li>How is the uptake for individual immune checkpoint inhibitor brands changing over time?<\/li>\n<li>Which brand is winning, and how does that vary by indication?<\/li>\n<li>How does the dynamic regulatory environment for immune checkpoint inhibitors in the U.S. affect prescribing patterns of currently approved immune checkpoint inhibitors by indication?<\/li>\n<li>What is the average claim charge for each immune checkpoint inhibitor brand and how much if the claim is paid?<\/li>\n<li>In which type of facilities are patients receiving immune checkpoint inhibitors?<\/li>\n<\/ul>\n","protected":false},"template":"","class_list":["post-576646","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-geography-us","biopharma-date-931"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/576646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/576646\/revisions"}],"predecessor-version":[{"id":577610,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/576646\/revisions\/577610"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=576646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}